Dandekar P V, Martin M C, Glass R H
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California-San Francisco 94143.
Fertil Steril. 1990 Mar;53(3):510-4.
Triploidy occurs in 1% to 3% of recognized conceptions in vivo. In vitro fertilization (IVF), which places large numbers of sperm in proximity to the oocyte, may increase the risk of triploidy. The risk also could be influenced by stimulation protocols that differentially affect egg quality. We found no significant difference in triploidy when cycles were stimulated with clomiphene citrate/human menopausal gonadotropin (3.2%) compared with gonadotropin-releasing hormone analog/human menopausal gonadotropin stimulation (4.4%). Triploidy was less common with male factor infertility (0.7%) compared with other causes of infertility (3.4% to 3.8%). Triploid embryos can develop to cleavage stages indistinguishable from those generated by diploid embryos. Thus, identifying and discarding embryos with greater than 2 pronuclei is a vital function of an IVF laboratory.
三倍体在体内已确认的妊娠中发生率为1%至3%。体外受精(IVF)将大量精子置于卵母细胞附近,可能会增加三倍体的风险。该风险也可能受不同程度影响卵子质量的刺激方案的影响。我们发现,与促性腺激素释放激素类似物/人绝经期促性腺激素刺激(4.4%)相比,使用枸橼酸氯米芬/人绝经期促性腺激素刺激周期时,三倍体发生率无显著差异(3.2%)。与其他不孕原因(3.4%至3.8%)相比,男性因素导致的不孕中三倍体较少见(0.7%)。三倍体胚胎可发育至与二倍体胚胎产生的胚胎难以区分的卵裂阶段。因此,识别并丢弃具有两个以上原核的胚胎是体外受精实验室的一项重要功能。